PE Ratio
33.49
-1.09-3.15%
Fri, 29 Nov 2024 21:07:29 GMT
Summary:
Supernus Pharmaceuticals price to earnings ratio is currently 33.49, with a fall of -1.09 (-3.15%) during the most recent trading day. Over the past year, it has dropped by -32.22 (-49.03%). SUPN PE ratio is now -91.47% below its all-time high of 392.41.SUPN PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SUPN PE Ratio Performance
| PeriodPeriod | PE ratioPE ratio | PricePrice | TTM EPSTTM EPS | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | -3.1% | -3.2% | +1093.8% | +3.5% |
| 1 m1 month | +6.3% | +6.3% | - | - |
| 3 m3 months | -91.2% | +4.5% | - | - |
| 6 m6 months | - | +34.8% | - | - |
| ytdytd | - | +23.8% | - | - |
| 1 y1 year | -49.0% | +33.0% | +160.9% | +6.8% |
| 5 y5 years | +182.1% | +53.2% | -45.7% | +59.7% |
SUPN PE Ratio High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 35.37 | -5.3% | 31.14 | +7.5% |
| 3 m | 3 months | 392.41 | -91.5% | 28.75 | +16.5% |
| 6 m | 6 months | 392.41 | -91.5% | 28.75 | +16.5% |
| 1 y | 1 year | 392.41 | -91.5% | 28.75 | +16.5% |
| 3 y | 3 years | 392.41 | -91.5% | 18.54 | +80.6% |
| 5 y | 5 years | 392.41 | -91.5% | 6.85 | +388.9% |
| alltime | all time | 392.41 | -91.5% | 1.62 | +1967.3% |
Supernus Pharmaceuticals PE Ratio History
| Date | Value |
|---|---|
| 2024 | 33.49(-3.3%) |
| 2022 | 34.63(+16.4%) |
| 2021 | 29.76(+179.2%) |
| 2020 | 10.66(-5.2%) |
| Date | Value |
|---|---|
| 2019 | 11.24(-30.3%) |
| 2018 | 16.13(-57.1%) |
| 2017 | 37.59(+153.1%) |
| 2016 | 14.85(-69.1%) |
| 2015 | 48.00 |
FAQ
- What is Supernus Pharmaceuticals price to earnings ratio?
- What is the all time high PE ratio for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals PE ratio year-on-year change?
What is Supernus Pharmaceuticals price to earnings ratio?
The current PE ratio of SUPN is 33.49
What is the all time high PE ratio for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high price to earnings ratio is 392.41
What is Supernus Pharmaceuticals PE ratio year-on-year change?
Over the past year, SUPN price to earnings ratio has changed by -32.22 (-49.03%)